[Pubmed] FDA go-ahead for myasthenia gravis agent
Posté : 19 janv. 2022 12:00
Nat Biotechnol. 2022 Jan;40(1):4. doi: 10.1038/s41587-021-01198-7.
NO ABSTRACT
PMID:35043016 | DOI:10.1038/s41587-021-01198-7
Source: https://pubmed.ncbi.nlm.nih.gov/3504301 ... 6&v=2.17.5